In the published article, there was an error in the number of ongoing clinical trial for HER2-positive unresectable or metastatic EMPD “(UMIN-000006629)”. Instead of “(UMIN-000006629)”, it should be “(UMIN000021311)”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The original article has been updated.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
metastatic extramammary Paget’s disease, HER2–PI3K/ERK signaling, lymphangiogenesis, CXCR4–stromal cell-derived factor-1 axis, CD163+M2 macrophage, receptor activator of nuclear factor kappa-B ligand–RANK signaling, mismatch-repair deficient, anti-PD-1 antibody
Citation
Fukuda K and Funakoshi T (2018) Corrigendum: Metastatic Extramammary Paget’s Disease: Pathogenesis and Novel Therapeutic Approach. Front. Oncol. 8:47. doi: 10.3389/fonc.2018.00047
Received
19 February 2018
Accepted
19 February 2018
Published
12 March 2018
Approved by
Frontiers in Oncology Editorial Office, Frontiers, Switzerland
Volume
8 - 2018
Updates
Copyright
© 2018 Fukuda and Funakoshi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Takeru Funakoshi, takeruf@a8.keio.jp
Specialty section: This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.